Significance Of Medical Case Reports Grows

Main Category: Primary Care / General Practice
Article Date: 19 Oct 2009 - 3:00 PDT

email to a friend   printer friendly   opinions  

BioMed Central is once again publishing the Journal of Medical Case Reports (JMCR) and Cases Journals. Since their inception, both these journals, which currently provide over 2000 freely accessible case reports have received widespread recognition and high quality submissions from across the medical community. Through their innovative approach, both these journals make each individual patient's case a valuable addition to medical literature.

Professor Michael Kidd from Flinders University in Australia and Editor-in-Chief of JMCR said: "It's great to be back with BioMed Central. We have published many landmark clinical cases across all areas of medicine including cancer, ophthalmology, primary care, gastroenterology, infectious diseases, and musculoskeletal disorders that have significantly contributed to medical knowledge." These cases can often serve as early warning signals for the adverse effects of new medications, or the presentations of new and emerging diseases. Cases Journal which is edited by regular Guardian columnist Richard Smith, will look to complete the scientific record for future generations by publishing any report that is understandable, ethical, authentic, and includes all information essential to its interpretation.

Over the past few years, authors have submitted case reports to these journals from countries as far afield as Nepal and Iran. This once again signifies the inherent value that case reports have to improving clinical practice globally and also the increasing power of the Internet to allow for the widespread sharing of knowledge and thus the advancement of the understanding and treatment of diseases.

Speaking of the return of JMCR and Cases Journal to BioMed Central's publishing portfolio Deborah Kahn, Publishing Director, said: "As the clinical significance and use of case reports continues to grow, the return of these two journals significantly bolsters BioMed Central's growing journal portfolio, and demonstrates our continued commitment to ensuring all research remains freely accessible to all."

Source:
Matt McKay
BioMed Central

• Additional
• References
• Citations